Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.56 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | DRD1 | P21728 | 1/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3796363 | 1.00 | TDP1 (0.56) | TDP1CYP1A2ADRB2ADRB1CYP3A4 | |
| SCHEMBL10993216 | 1.00 | TDP1 (0.56) | TDP1CYP1A2ADRB2ADRB1CYP3A4 | |
| SCHEMBL5272608 | 0.83 | ALDH1A1 (0.52) | TDP1CYP1A2ADRB2ADRB1CYP3A4 | |
| SCHEMBL11112482 | 0.80 | SMN1; SMN2 (0.56) | TDP1CYP1A2ADRB2ADRB1CYP3A4 | |
| SCHEMBL10357600 | 0.80 | CYP1A2 (0.48) | TDP1CYP1A2ADRB2ADRB1CYP3A4 | |
| SCHEMBL9393155 | 0.80 | ALDH1A1 (0.50) | TDP1CYP1A2ADRB2ADRB1CYP3A4 | |
| SCHEMBL12916553 | 0.80 | TDP1 (0.67) | TDP1CYP1A2ADRB2ADRB1CYP3A4 | |
| SCHEMBL10749130 | 0.79 | KMT2A (0.58) | TDP1CYP1A2ADRB2ADRB1CYP3A4 | |
| SCHEMBL18074878 | 0.77 | CYP1A2 (0.63) | TDP1CYP1A2ADRB2ADRB1CYP3A4 | |
| SCHEMBL14916801 | 0.75 | CYP1A2 (0.67) | TDP1CYP1A2ADRB2ADRB1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4195085-A | Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate | MERCK & CO., INC. (US) | 1980-03-25 | — | — | US | claimed |
| WO-2014025365-A1 | EYELID TREATMENT | TANG GORDON C (US) | 2014-02-13 | — | — | WO | disclosed |
| EP-0452151-B1 | Substituted aromatic sulfonamides as antiglaucoma agents | MERCK & CO INC (US) | 1997-07-16 | — | — | EP | disclosed |
| EP-0411702-B1 | 4-(2-methyl-2-hydroxypropyl-amino)-5,6-dihydrothieno-2(2,3-B)thiopyran-2-sulfonamide-7,7-dioxide | MERCK & CO INC (US) | 1995-01-11 | — | — | EP | disclosed |
| EP-0411704-B1 | Substituted aromatic sulfonamides as antiglaucoma agents | MERCK & CO INC (US) | 1995-01-11 | — | — | EP | disclosed |
| US-5334591-A | Useful in the treatment of ocular hypertension and glaucoma | MERCK & CO., INC. (US) | 1994-08-02 | — | — | US | disclosed |
| US-5308842-A | Ocular hypotensive agents; glaucoma | MERCK & CO., INC. (US) | 1994-05-03 | — | — | US | disclosed |
| US-5308863-A | Carbonic anhydrase inhibitors | MERCK & CO., INC. (US) | 1994-05-03 | — | — | US | disclosed |
| US-5276025-A | Heterobicyclic sulfonamides | MERCK & CO., INC. (US) | 1994-01-04 | — | — | US | disclosed |
| EP-0307084-B1 | Substituted thieno(2,3-b)thiophene-2-sulfonamides as antiglaucoma agents | MERCK & CO INC (US) | 1993-12-15 | — | — | EP | disclosed |
| US-4820848-A | Substituted aromatic sulfonamides as antiglaucoma agents | MERCK & CO., INC. (US) | 1989-04-11 | — | — | US | disclosed |
| EP-0309028-A2 | Substituted thieno(2,3-B)furan-2-sulfonamides as antiglaucoma agents | MERCK & CO. INC. (US) | 1989-03-29 | — | — | EP | disclosed |
| EP-0307084-A1 | Substituted thieno(2,3-b)thiophene-2-sulfonamides as antiglaucoma agents | MERCK & CO. INC. (US) | 1989-03-15 | — | — | EP | disclosed |
| US-4797413-A | Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use | MERCK & CO., INC. (US) | 1989-01-10 | — | — | US | disclosed |
| EP-0271273-A2 | Thieno-and furopyridine sulfonamides | MERCK & CO. INC. (US) | 1988-06-15 | — | — | EP | disclosed |
| EP-0252640-A1 | Alkanesulfonamides as antiglaucoma agents | MERCK & CO. INC. (US) | 1988-01-13 | — | — | EP | disclosed |
| EP-0228237-A1 | Substituted thiophene-2-sulfonamide antiglaucoma agents | MERCK & CO. INC. (US) | 1987-07-08 | — | — | EP | disclosed |
| EP-0155214-A2 | 2-sulfamoyl-1H-indole derivatives for the treatment of elevated intraocular pressure | MERCK & CO. INC. (US) | 1985-09-18 | — | — | EP | disclosed |
| US-4521414-A | 1-TERT-BUTYLAMINO-3-((4-MORPHOLINO-1,2,5-THIADIAZOL-3-YL)OXY)-2 -PROPANOL AND SALTS THERFOF | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 1985-06-04 | — | — | US | disclosed |
| EP-0105996-A1 | Ophthalmic compositions for treating elevated intraocular pressure | MERCK & CO. INC. (US) | 1984-04-25 | — | — | EP | disclosed |